Merck & Co., Inc. is 112.4x more valuable than SUPERNUS PHARMACEUTICALS, INC. by market capitalization ($294.13 B vs $2.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SUPN | MRK |
|---|---|---|
| Market cap | $2.62 B | $294.13 B |
| US-listed rank | #1908 | #44 |
| Revenue (latest FY) | $718.95M | $65.01B |
| Net income (latest FY) | -$38.60M | $18.25B |
| Net margin | -5.4% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 1,154 | 996 |
Merck & Co., Inc. is 112.4x more valuable than SUPERNUS PHARMACEUTICALS, INC. by market capitalization ($294.13 B vs $2.62 B).
In their latest fiscal years, SUPERNUS PHARMACEUTICALS, INC. reported $718.95M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: SUPERNUS PHARMACEUTICALS, INC. and Merck & Co., Inc., or browse the full rankings.